Skip to main content
. 2005 Jan 20;6(1):8. doi: 10.1186/1465-9921-6-8

Figure 4.

Figure 4

Potential target sites for therapeutic strategies. In view of the viral life cycle, there are several potential targets for the development of antiviral drugs. Starting from the binding of the virus to the target cell, the spike protein or receptors such as angiotension-converting enzyme 2 (ACE2), cell entry or the different replication steps may be targeted. After replication, virus assembly and exit mechanisms may also be used for antiviral strategies. VLP, virus-like particles.